Savage; Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Savage; Scott.The latest application filed is for "polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production".

Company Profile

6.9.12

Savage; Scott - Burlingame CA
SAVAGE; Scott - Redwood City CA
Savage; Scott - South San Francisco CA
Savage; Scott - Fort Collins CO
Savage; Scott - Ft. Collins CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production Grant 11,028,100 - Chakravarty , et al. June 8, 2	2021-06-08
Polymorphs And Solid Forms Of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- F]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, And Methods Of Production App 20210094970 - Chakravarty; Paroma ; et al.	2021-04-01
Use Of Neutrophil Elastase Inhibitors In Liver Disease App 20210069192 - SATYAL; Sanjeev ; et al.	2021-03-11
Polymorphs And Solid Forms Of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- F]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, And Methods Of Production App 20200399286 - Chakravarty; Paroma ; et al.	2020-12-24
Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds Grant 10,870,626 - Gosselin , et al. December 22, 2	2020-12-22
Use of neutrophil elastase inhibitors in liver disease Grant 10,806,735 - Satyal , et al. October 20, 2	2020-10-20
Process for the preparation of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- F]imidazo[1,2-D][1,4]oxazepin-9-yl)amino) propanamide Grant 10,781,219 - Gosselin , et al. Sept	2020-09-22
PROCESS FOR PREPARING (CYCLOPENTYL[d]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS App 20200010428 - Gosselin; Francis ; et al.	2020-01-09
Process for preparing (cyclopentyl[d]pyrimidin-4-yl)piperazine compounds Grant 10,457,648 - Gosselin , et al. Oc	2019-10-29
Use Of Neutrophil Elastase Inhibitors In Liver Disease App 20190321364 - Satyal; Sanjeev ; et al.	2019-10-24
Process For The Preparation Of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- F]imidazo[1,2-d][1,4]o App 20190292201 - GOSSELIN; Francis ; et al.	2019-09-26
Polymorphs And Solid Forms Of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[- F]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, And Methods Of Production App 20180339997 - Chakravarty; Paroma ; et al.	2018-11-29
Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-y- l)phenyl)acrylic acid Grant 9,975,856 - Bachmann , et al. May 22, 2	2018-05-22
PROCESS FOR PREPARING (CYCLOPENTYL[d]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS App 20170247338 - Gosselin; Francis ; et al.	2017-08-31
Process For The Preparation Of (e)-3-(4-((e)-2-(2-chloro-4-fluorophenyl)-1-(1h-indazol-5-yl)but-1-en-1-y- L)phenyl)acrylic Acid App 20170101380 - Bachmann; Stephan ; et al.	2017-04-13
High efficiency voltage level multiplier Grant 9,473,018 - Savage , et al. October 18, 2	2016-10-18
High Efficiency Voltage Level Multiplier App 20150326111 - Savage; Scott ; et al.	2015-11-12
CMOS level shifters using native devices Grant 6,803,801 - Randazzo , et al. October 12, 2	2004-10-12
CMOS level shifters using native devices App 20040090259 - Randazzo, Todd ; et al.	2004-05-13
Slew based clock multiplier Grant 6,664,812 - Savage December 16, 2	2003-12-16
Slew based clock multiplier App 20030189444 - Savage, Scott	2003-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.